Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01792882

Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Global BioClinical · Industry
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The study is intended to collect specimens to support the application of genome analysis technologies, including large-scale genome sequencing. This study will ultimately provide cancer researchers with specimens that they can use to develop comprehensive catalogs of genomic information on at least 50 types of human cancer. The study will create a resource available to the worldwide research community that could be used to identify and accelerate the development of new diagnostic and prognostic markers, new targets for pharmaceutical interventions, and new cancer prevention and treatment strategies. This study will be a competitive enrollment study conducted at multiple institutions.

Detailed description

This study will enroll subjects diagnosed with various cancers and who are scheduled to undergo surgical treatment. Prior to scheduled surgery, subjects will be asked to donate a 10-20 ml blood sample. After surgery, surplus tissues (including tumor and adjacent normal tissues) not required for diagnosis will be collected. Subject clinical information will be collected, including basic demographic information, medical history, family history, current cancer history and treatment. After surgery, a final pathology report will be obtained for each subject's surgical specimen. In some instances and based on the cancer indications required, longitudinal data may also be collected at a frequency of every 6 months to once per year. Longitudinal data will include information on study subject survival and disease recurrence.

Conditions

Timeline

Start date
2013-02-01
Primary completion
2022-12-31
Completion
2023-02-27
First posted
2013-02-15
Last updated
2023-02-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01792882. Inclusion in this directory is not an endorsement.